Improved Therapeutic Benefits by Combining Physical Cooling With Pharmacological Hypothermia After Severe Stroke in Rats
Background and Purpose Therapeutic hypothermia is a promising strategy for treatment of acute stroke. Clinical translation of therapeutic hypothermia, however, has been hindered because of the lack of efficiency and adverse effects. We sought to enhance the clinical potential of therapeutic hypothermia by combining physical cooling (PC) with pharmacologically induced hypothermia after ischemic stroke. Methods Wistar rats were subjected to 90 minute middle cerebral artery occlusion by insertion of an intraluminal filament. Mild to moderate hypothermia was induced 120 minutes after the onset of stroke by PC alone, a neurotensin receptor 1 (NTR1) agonist HPI 201 (formally ABS 201) alone or the combination of both. The outcomes of stroke were evaluated at 3 and 21 days after stroke. Results PC or HPI 201 each showed hypothermic effect and neuroprotection in stroke rats. The combination of PC and HPI 201 exhibited synergistic effects in cooling process, reduced infarct formation, cell death, and blood brain barrier damages and improved functional recovery after stroke. Importantly, coapplied HPI 201 completely inhibited PC associated shivering and tachycardia. Conclusions The centrally acting hypothermic drug HPI 201 greatly enhanced the efficiency and efficacy of conventional PC; this combined cooling therapy may facilitate clinical translation of hypothermic treatment for stroke.
Stroke